This trial is designed to evaluate the use of the patient’s own bone marrow stem cells to treat Age Related Macular Degeneration. The trial is being conducted by the University of Sao Paulo and expects to enrol 10 subjects by September 2013. Participants will have the stem cells injected directly into their eye (intravitreal injection). Participants will be monitored for complications as well as structural evidence of successful engraftment and changes to vision.